Personalize Colorectal Cancer Treatment with Myriad Oncology Tests
1 in 5 have familiar clustering1
Tumor testing alone can overlook up to 10% of key genetic variants2
Currently, only 6% of patients receive potentially life-saving genetic insights3,4
Based on national guidelines for cancer care,5,6,7 Fiona meets the criteria for combined germline and tumor genomic testing. These guidelines, established by leading oncology organizations, recommend comprehensive genetic profiling for patients like Fiona to inform treatment decisions and assess hereditary risk factors.
MyRisk® Hereditary Cancer Test identified a positive MLH1 pathogenic variant in Fiona's case, diagnosing Lynch syndrome. This critical information enables:
Precise Tumor® Molecular Profile Test uncovered:
Tailoring Treatment Strategies
Myriad’s industry-leading variant reclassification program ensures that each variant of uncertain significance (VUS) is continuously re-evaluated until a definitive classification is available.
Pre- and post-test education as live, point-of-care sessions with a board-certified Genetic Counselor
Transparent pricing with personalized cost estimates, financial assistance, and other affordability options, including direct pay
Consolidated germline and tumor genomic results are available on average of 14 days after lab receives the sample
Medical Science Liason’s support providers and their teams in answering clinical, testing, and results-related questions
Myriad’s Variant Classification Program includes a Lifetime Reclassification Commitment to send amended reports if a variant of uncertain significance (VUS) is reclassified and is clinically actionable
MYRIAD ONCOLOGY
EXPLORE THE FULL MYRIAD ONCOLOGY PORTFOLIO
Request more information about how Myriad’s Oncology solutions can benefit you/your patients.
By submitting your personal information, you agree to be contacted with newsletters, marketing or promotional materials, and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in the communication we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Notice.
Contact Information